Therapy Areas
13 November 2018 - - US-based biopharmaceutical company Gilead Sciences, Inc. (NASDAQ: GILD) has presented new data from the company's clinical development programme for advanced fibrosis due to nonalcoholic steatohepatitis, the company said.
13 November 2018 - - US-based immunotherapy company Alpine Immune Sciences, Inc. (NASDAQ: ALPN) has advanced its oncology programme, the company said.

Following promising preclinical data presented TODAY at the Society for Immunotherapy ...
13 November 2018 - - US-based biotechnology company Obsidian Therapeutics, Inc has presented preclinical data demonstrating fine-tuned regulation of cytokine production and CAR-T function using Destabilizing Domains paired with FDA-approved small mol...
13 November 2018 - - Analysts at UK-based technology research and advisory company Technavio  forecast the global cervical cancer diagnostic testing market to grow at a CAGR of over 6% during the forecast period, according to their latest m...
13 November 2018 - - US-based biopharmaceutical company Omeros Corp. (NASDAQ: OMER) has priced an offering of USD 210m aggregate principal amount of its 6.25% convertible senior notes due 2023 in a private offering to qualified institutional buyers p...
13 November 2018 - - Japanese drugmaker Eisai Co., Ltd. and US-based Merck (NYSE: MRK) have received results from presentations of new data and analyses of Lenvima (lenvatinib), an orally available kinase inhibitor discovered by Eisai, in combination...
13 November 2018 - - The US Food and Drug Administration has cleared two investigational new drug applications for US-based immuno-oncology biotechnology company Fortis Therapeutics, Inc's lead candidate, FOR46, for the treatment of metastatic c...